MX2020002527A - Compuestos de complejo de hierro para uso terapeutico. - Google Patents

Compuestos de complejo de hierro para uso terapeutico.

Info

Publication number
MX2020002527A
MX2020002527A MX2020002527A MX2020002527A MX2020002527A MX 2020002527 A MX2020002527 A MX 2020002527A MX 2020002527 A MX2020002527 A MX 2020002527A MX 2020002527 A MX2020002527 A MX 2020002527A MX 2020002527 A MX2020002527 A MX 2020002527A
Authority
MX
Mexico
Prior art keywords
complex compounds
iron complex
therapeutic use
iron
arsenic
Prior art date
Application number
MX2020002527A
Other languages
English (en)
Inventor
Tobias S Christensen
Hans B Andreasen
Original Assignee
Pharmacosmos Holding As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacosmos Holding As filed Critical Pharmacosmos Holding As
Publication of MX2020002527A publication Critical patent/MX2020002527A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/02—Iron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Abstract

La presente invención se refiere a compuestos de complejo de hierro para uso terapéutico que son bajos en arsénico, cromo, plomo, cadmio, mercurio y/o aluminio, a composiciones de los mismos y a procesos de preparación de dichos compuestos de complejo de hierro.
MX2020002527A 2017-09-11 2018-09-10 Compuestos de complejo de hierro para uso terapeutico. MX2020002527A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17190302 2017-09-11
PCT/EP2018/074293 WO2019048674A1 (en) 2017-09-11 2018-09-10 COMPLEX IRON COMPOUNDS FOR THERAPEUTIC USE

Publications (1)

Publication Number Publication Date
MX2020002527A true MX2020002527A (es) 2020-10-12

Family

ID=59923237

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2020002527A MX2020002527A (es) 2017-09-11 2018-09-10 Compuestos de complejo de hierro para uso terapeutico.
MX2023007809A MX2023007809A (es) 2017-09-11 2020-03-05 Compuestos de complejo de hierro para uso terapeutico.
MX2023007810A MX2023007810A (es) 2017-09-11 2020-03-05 Compuestos de complejo de hierro para uso terapeutico.

Family Applications After (2)

Application Number Title Priority Date Filing Date
MX2023007809A MX2023007809A (es) 2017-09-11 2020-03-05 Compuestos de complejo de hierro para uso terapeutico.
MX2023007810A MX2023007810A (es) 2017-09-11 2020-03-05 Compuestos de complejo de hierro para uso terapeutico.

Country Status (12)

Country Link
US (2) US11111261B2 (es)
EP (1) EP3681539A1 (es)
JP (2) JP7426927B2 (es)
KR (1) KR20200044030A (es)
CN (1) CN111050802A (es)
AU (1) AU2018328052B2 (es)
BR (1) BR112020004357A2 (es)
MA (1) MA50229A (es)
MX (3) MX2020002527A (es)
SG (1) SG11202001594TA (es)
WO (1) WO2019048674A1 (es)
ZA (1) ZA202001283B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020004357A2 (pt) * 2017-09-11 2020-09-08 Pharmacosmos Holding A/S compostos de complexo de ferro para uso terapêutico
CA3125413A1 (en) 2019-01-10 2020-07-16 Pharmacosmos Holding A/S Treating iron deficiency in subjects at risk of cardiovascular adverse events and iron for the management of atrial fibrillation
CN114286682A (zh) 2019-02-09 2022-04-05 法码科思莫斯控股有限公司 治疗具有心血管不良事件风险的个体的铁缺乏以及用于治疗心房颤动的铁
WO2020176894A1 (en) 2019-02-28 2020-09-03 Renibus Therapeutics, Inc. Novel iron compositions and methods of making and using the same
CA3226771A1 (en) 2021-08-03 2023-02-09 Pharmacosmos Holding A/S Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals
CN117379387A (zh) * 2022-01-13 2024-01-12 上海医药集团青岛国风药业股份有限公司 一种多糖铁胶囊内容组合物及方法
CN115177625A (zh) * 2022-06-28 2022-10-14 金陵药业股份有限公司 一种羧基麦芽糖铁药用组合物及其制备方法
KR102623739B1 (ko) * 2022-07-28 2024-01-11 주식회사 페라메드 시트르산과 철을 포함하는 착화합물 및 그를 포함하는 식품 조성물

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR607134A (fr) 1924-12-03 1926-06-26 Basf Ag Procédé pour la production du fer carbonyle
FR654013A (fr) * 1928-05-09 1929-03-30 Procédé de réglage de la carburation dans les moteurs à explosions et dispositifen permettant la réalisation
US2096855A (en) * 1934-07-27 1937-10-26 Innis Speiden & Co Manufacture of ferric chloride
US3639588A (en) 1966-10-22 1972-02-01 Fisons Pharmaceuticals Ltd Pharmaceutical compositions containing ferric hydroxide complexed with dextran or dextrin heptonic acids
US3906077A (en) 1974-02-15 1975-09-16 Kerr Mc Gee Chem Corp Purification of ferric chloride
US4056386A (en) 1977-04-19 1977-11-01 The United States Of America As Represented By The Secretary Of The Navy Method for decomposing iron pentacarbonyl
WO1999043408A1 (en) 1998-02-25 1999-09-02 Wadhawan Satish C Solvent extraction of ferric chloride
DK172860B1 (da) 1998-03-25 1999-08-16 Pharmacosmos Holding As Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
DK173138B1 (da) 1998-11-20 2000-02-07 Pharmacosmos Holding As Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma
US7871597B2 (en) 1999-04-09 2011-01-18 Amag Pharmaceuticals, Inc. Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US20060134227A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Compositions including iron
ITMO20050056A1 (it) * 2005-03-15 2006-09-16 Biofer Spa Processo per la preparazione di complessi del ferro trivalente con zuccheri mono-, di- e polisaccaridi.
EA019635B1 (ru) 2007-02-06 2014-05-30 Медикал Ресёрч Каунсил Лиганд-модифицированные полиоксогидроксидные материалы с ионами металла, их применение и способы их получения
GB0702270D0 (en) * 2007-02-06 2007-03-14 Medical Res Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
SI2411053T1 (sl) 2009-03-25 2017-04-26 Pharmacosmos Holding A/S Stabilna spojina železovega oligosaharida
CN102065406B (zh) 2009-11-12 2014-04-09 中兴通讯股份有限公司 一种本地呼叫本地交换的实现方法
WO2016066172A1 (en) 2014-10-27 2016-05-06 Pharmacosmos Holding A/S Treatment or prevention of anaemia in pregnant non-human mammals
EP2913054A1 (en) * 2015-03-19 2015-09-02 Pharmacosmos Holding A/s Iron carbohydrate complex for treatment of restless leg syndrome (rls)
WO2016181195A1 (en) * 2015-05-08 2016-11-17 Suven Life Sciences Limited Improved process for water soluble iron carbohydrate complexes
EP3310364B1 (en) 2015-06-22 2021-09-15 Pharmacosmos Holding A/s Iron carbohydrate complex for treatment of iron deficiency of a fetus or an infant
CN105095365A (zh) 2015-06-26 2015-11-25 北京奇虎科技有限公司 一种信息流数据的处理方法和装置
KR102190963B1 (ko) * 2016-05-20 2020-12-15 옵쉐스트바 스 아그라니첸너이아트?洲뵈?벤너스찌유 ＂빅-즈다로비예쥐 보트니흐＂ 빈혈의 예방 및 치료를 위한 비타민을 함유하는 철 덱스트란 복합체의 즉시 사용가능한 주사 가능한 조성물
BR112020004357A2 (pt) * 2017-09-11 2020-09-08 Pharmacosmos Holding A/S compostos de complexo de ferro para uso terapêutico

Also Published As

Publication number Publication date
US20220041640A1 (en) 2022-02-10
MA50229A (fr) 2020-07-22
RU2020113257A (ru) 2021-10-13
CN111050802A (zh) 2020-04-21
AU2018328052B2 (en) 2024-02-29
JP2023164477A (ja) 2023-11-10
MX2023007809A (es) 2023-07-11
MX2023007810A (es) 2023-07-11
JP2020533300A (ja) 2020-11-19
ZA202001283B (en) 2022-11-30
SG11202001594TA (en) 2020-03-30
BR112020004357A2 (pt) 2020-09-08
EP3681539A1 (en) 2020-07-22
AU2018328052A1 (en) 2020-03-26
US11111261B2 (en) 2021-09-07
RU2020113257A3 (es) 2022-04-25
KR20200044030A (ko) 2020-04-28
US20190177353A1 (en) 2019-06-13
WO2019048674A1 (en) 2019-03-14
JP7426927B2 (ja) 2024-02-02

Similar Documents

Publication Publication Date Title
MX2023007809A (es) Compuestos de complejo de hierro para uso terapeutico.
PH12019502875A1 (en) Antibody molecules to cd73 and uses thereof
MX2020009649A (es) Anticuerpos monoclonales contra bcma.
PH12018502225A1 (en) Anti-il-33 antibodies, compositions, methods and uses thereof
ZA201906832B (en) Novel psma-binding agents and uses thereof
MX2018014154A (es) Polinucleotidos moduladores.
MX2018006240A (es) Composiciones que comprenden cepas bacterianas.
PH12016501763A1 (en) Multispecific antibodies
MX2019003623A (es) Composiciones y metodos para el tratamiento de afecciones oftalmicas.
MA42471A (fr) Compositions comprenant des souches bactériennes
NZ738008A (en) Tigit-binding agents and uses thereof
MX2019007021A (es) Anticuerpos il-11ra.
MX2022015755A (es) Profarmacos de hormona paratiroidea (pth).
MX2019011496A (es) Composiciones de niraparib.
MX2020009223A (es) Anticuerpos anti-fgfr2iiib afucosilados.
PH12017502207A1 (en) Tau-binding antibodies
PH12019502002A1 (en) Combination theraphy
MX2018000715A (es) Metodos para tratar cancer usando apilimod.
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
PH12021550102A1 (en) Cardiosafe antidiabetic therapy
GB2568181A (en) Wheat
MX2017010883A (es) Composicion para el tratamiento de la infertilidad.
MX2019003755A (es) Regimen de dosificacion de avelumab para el tratamiento de cancer.
MX2019014714A (es) Anticuerpos anti-trkb.
MX2017010526A (es) Mezclas de aceite, procesos para la preparacion de estas y su uso en formulas.